Clinical Trial: Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy (NAION)

Brief Summary: The purpose of this study is to explore the safety and efficacy of ranibizumab to treat non-arteritic ischemic optic neuropathy based on clinical and anatomical findings.